The year's new drugs.
Forty-four new chemical entities and biological drugs and two diagnostic agents reached their first markets in 2000. Gastrointestinal Drugs was the most active therapeutic group in terms of new launches, with seven market introductions, and the United States was once again the most active single market for new products, with a total of 17 new launches in 2000, constituting 37% of all new introductions for the year.